| mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
4e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
| mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0003 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0004 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |